Glass House Brands announced today that its subordinate voting shares have been approved for listing on the New York Stock Exchange, with trading expected to begin next week under the ticker symbol GLAS.

The company said the shares are expected to begin trading on the NYSE at the opening of trading on June 30. Glass House anticipates that the shares will continue trading on the OTCQX under the symbol GLASF until the close of market on June 29, while continuing to trade on Cboe Canada under the symbol GLAS.A.U.

Current shareholders do not need to take any action ahead of the expected listing, according to the company.

Kyle Kazan, co-founder, chairman and CEO of Glass House, called the NYSE listing “an important developmental milestone” for both the company and the broader cannabis industry. He said the move “was not possible prior to the recent reclassification of medical cannabis to Schedule III.”

“Beyond the listing, we remain encouraged by the opportunities presented by rescheduling,” Kazan said, adding that Glass House believes it is positioned to benefit from potential developments including interstate commerce and the export of medical cannabis to Europe.

The announcement comes a week after Glass House said it had applied to list its subordinate voting shares on the NYSE while moving to deconsolidate its dual-use cannabis business from its medical cannabis business.

Glass House, headquartered in Long Beach, California and Toronto, is focused on the California market and operates a portfolio that includes Glass House Farms, PLUS Products, Allswell and Mama Sue Wellness.

The expected NYSE debut follows a growing push among major cannabis companies to access senior U.S. exchanges following the federal government’s recent move to place certain medical marijuana products in Schedule III.